Literature DB >> 20930848

The history of p53. A perfect example of the drawbacks of scientific paradigms.

Thierry Soussi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930848      PMCID： PMC2966958          DOI： 10.1038/embor.2010.159

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  42 in total

1.  SV40 large T-antigen and transformation related protein p53 are associated in situ with nuclear RNP structures containing hnRNA of transformed cells.

Authors:  C Caron de Fromentel; A Viron; E Puvion; P May
Journal:  Exp Cell Res       Date:  1986-05       Impact factor: 3.905

2.  Consistent deficiencies of chromosome 18 and of the short arm of chromosome 17 in eleven cases of human large bowel cancer: a possible recessive determinism.

Authors:  M Muleris; R J Salmon; B Zafrani; J Girodet; B Dutrillaux
Journal:  Ann Genet       Date:  1985

3.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

4.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.

Authors:  W Maltzman; L Czyzyk
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

Review 5.  Use of transfection to analyze genetic information and malignant transformation.

Authors:  R A Weinberg
Journal:  Biochim Biophys Acta       Date:  1981-08-31

Review 6.  The 53,000-dalton cellular protein and its role in transformation.

Authors:  L Crawford
Journal:  Int Rev Exp Pathol       Date:  1983

7.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus.

Authors:  M Mowat; A Cheng; N Kimura; A Bernstein; S Benchimol
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

8.  Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer.

Authors:  L V Crawford; D C Pim; R D Bulbrook
Journal:  Int J Cancer       Date:  1982-10-15       Impact factor: 7.396

9.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962
View more
  12 in total

Review 1.  Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain.

Authors:  Grasiella A Andriani; Jan Vijg; Cristina Montagna
Journal:  Mech Ageing Dev       Date:  2016-03-21       Impact factor: 5.432

2.  Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.

Authors:  Ugo Borges Pinheiro; Carlos Alberto de Carvalho Fraga; Danilo Cangussu Mendes; Lucyana Conceição Farias; Cláudio Marcelo Cardoso; Christine Mendes Silveira; Marcos Flávio Silveira Vasconcelos D'Angelo; Kimberly Marie Jones; Sérgio Henrique Souza Santos; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Tumour Biol       Date:  2015-06-23

Review 3.  Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors:  April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

Review 4.  Precision Oncology: The Road Ahead.

Authors:  Daniela Senft; Mark D M Leiserson; Eytan Ruppin; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2017-09-05       Impact factor: 11.951

5.  Molecular biology of gynecological cancer.

Authors:  Kenzo Sonoda
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

6.  Bifurcation analysis of bistable and oscillatory dynamics in biological networks using the root-locus method.

Authors:  Neslihan Avcu; Cüneyt Güzeliş
Journal:  IET Syst Biol       Date:  2019-12       Impact factor: 1.615

Review 7.  The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.

Authors:  Stephen R Armstrong; Hong Wu; Benfan Wang; Yasser Abuetabh; Consolato Sergi; Roger P Leng
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

Review 8.  Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies.

Authors:  Vitaly Chasov; Mikhail Zaripov; Regina Mirgayazova; Raniya Khadiullina; Ekaterina Zmievskaya; Irina Ganeeva; Aigul Valiullina; Albert Rizvanov; Emil Bulatov
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

Review 9.  Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment.

Authors:  Valentina Rocca; Giovanni Blandino; Lucia D'Antona; Rodolfo Iuliano; Silvia Di Agostino
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

10.  Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.

Authors:  Silvia Darb-Esfahani; Carsten Denkert; Albrecht Stenzinger; Christoph Salat; Bruno Sinn; Christian Schem; Volker Endris; Peter Klare; Wolfgang Schmitt; Jens-Uwe Blohmer; Wilko Weichert; Markus Möbs; Hans Tesch; Sherko Kümmel; Peter Sinn; Christian Jackisch; Manfred Dietel; Toralf Reimer; Sherene Loi; Michael Untch; Gunter von Minckwitz; Valentina Nekljudova; Sibylle Loibl
Journal:  Oncotarget       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.